As of 2026-01-28, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 122.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.22 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 75.0%.
The range of the Relative Valuation is 99.05 - 161.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 25.1x | 22.4x |
| Forward P/E multiples | 22.0x - 34.5x | 28.2x |
| Fair Price | 99.05 - 161.70 | 122.87 |
| Upside | 41.1% - 130.3% | 75.0% |
| Date | P/E |
| 2026-01-27 | 13.87 |
| 2026-01-26 | 13.80 |
| 2026-01-23 | 13.67 |
| 2026-01-22 | 14.08 |
| 2026-01-21 | 14.16 |
| 2026-01-20 | 13.91 |
| 2026-01-16 | 14.06 |
| 2026-01-15 | 14.18 |
| 2026-01-14 | 14.41 |
| 2026-01-13 | 14.15 |
| 2026-01-12 | 14.30 |
| 2026-01-09 | 14.31 |
| 2026-01-08 | 14.24 |
| 2026-01-07 | 14.83 |
| 2026-01-06 | 14.44 |
| 2026-01-05 | 14.06 |
| 2026-01-02 | 13.89 |
| 2025-12-31 | 13.29 |
| 2025-12-30 | 13.37 |
| 2025-12-29 | 13.62 |
| 2025-12-26 | 13.60 |
| 2025-12-24 | 13.51 |
| 2025-12-23 | 13.50 |
| 2025-12-22 | 13.46 |
| 2025-12-19 | 13.30 |
| 2025-12-18 | 12.86 |
| 2025-12-17 | 12.99 |
| 2025-12-16 | 12.73 |
| 2025-12-15 | 12.53 |
| 2025-12-12 | 12.29 |
| 2025-12-11 | 12.22 |
| 2025-12-10 | 12.37 |
| 2025-12-09 | 12.22 |
| 2025-12-08 | 12.42 |
| 2025-12-05 | 12.51 |
| 2025-12-04 | 12.43 |
| 2025-12-03 | 12.77 |
| 2025-12-02 | 13.14 |
| 2025-12-01 | 13.45 |
| 2025-11-28 | 14.10 |
| 2025-11-26 | 14.35 |
| 2025-11-25 | 14.38 |
| 2025-11-24 | 14.61 |
| 2025-11-21 | 13.89 |
| 2025-11-20 | 13.62 |
| 2025-11-19 | 13.87 |
| 2025-11-18 | 13.84 |
| 2025-11-17 | 13.93 |
| 2025-11-14 | 13.83 |
| 2025-11-13 | 14.06 |